Skip to content
HowShorted

CORCEPT THERAPEUTICS INC short interest in 2019

In 2019, CORCEPT THERAPEUTICS INC's disclosed short interest ran from 22.13% of shares outstanding on 15 Jan 2019 to 19.25% on 31 Dec 2019, a change of -2.88 percentage points. The year's high was 22.13% on 15 Jan 2019 and its low 17.65% on 31 Oct 2019, averaging 20.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 49.57 days on 14 Jun 2019. Full history: CORCEPT THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CORCEPT THERAPEUTICS INC in 2019

2019 in figures

Start of year
22.13% (15 Jan 2019)
End of year
19.25% (31 Dec 2019)
Change
-2.88 pp
High
22.13% (15 Jan 2019)
Low
17.65% (31 Oct 2019)
Average
20.45%
Highest days to cover
49.57 (14 Jun 2019)
SEC filings marked
9

Every report in 2019

CORCEPT THERAPEUTICS INC short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201922.13%23.06
31 Jan 201921.93%10.57results (8-K)
15 Feb 201920.88%9.51
28 Feb 201921.10%17.26results (8-K), 10-K filed
15 Mar 201921.67%26.25
29 Mar 201921.83%33.17
15 Apr 201921.52%40.04
30 Apr 201920.79%32.97
15 May 201921.43%24.8110-Q filed, results (8-K)
31 May 201922.09%35.59
14 Jun 201922.00%49.57
28 Jun 201921.72%43.76
15 Jul 201921.28%48.20
31 Jul 201920.56%37.08
15 Aug 201920.59%26.1410-Q filed, results (8-K)
30 Aug 201920.51%46.51
13 Sep 201919.40%29.59
30 Sep 201918.36%23.92
15 Oct 201918.49%34.13
31 Oct 201917.65%37.56
15 Nov 201917.67%21.0310-Q filed, results (8-K)
29 Nov 201918.67%10.77
13 Dec 201919.17%21.61
31 Dec 201919.25%30.47

See also: CORCEPT THERAPEUTICS INC's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.